Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences

BACKGROUND: For patients receiving daily opioid agonist treatment (OAT) for opioid dependence, several countries relaxed treatment guidelines at the beginning of the COVID-19 pandemic. This involved longer take-home intervals for methadone and buprenorphine doses as well as a reduction in supervised...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonald, Rebecca, Bech, Anne Berit, Clausen, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485985/
https://www.ncbi.nlm.nih.gov/pubmed/37679751
http://dx.doi.org/10.1186/s12913-023-09959-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485985/
https://www.ncbi.nlm.nih.gov/pubmed/37679751
http://dx.doi.org/10.1186/s12913-023-09959-7

Ejemplares similares